284 related articles for article (PubMed ID: 23770322)
21. Assessment of steroidogenesis and steroidogenic enzyme functions.
Luu-The V
J Steroid Biochem Mol Biol; 2013 Sep; 137():176-82. PubMed ID: 23770321
[TBL] [Abstract][Full Text] [Related]
22. 3beta-hydroxysteroid dehydrogenase/delta5-->4-isomerase activity associated with the human 17beta-hydroxysteroid dehydrogenase type 2 isoform.
Suzuki T; Sasano H; Andersson S; Mason JI
J Clin Endocrinol Metab; 2000 Oct; 85(10):3669-72. PubMed ID: 11061520
[TBL] [Abstract][Full Text] [Related]
23. The EPI bioassay identifies natural compounds with estrogenic activity that are potent inhibitors of androgenic pathways in human prostate stromal and epithelial cells.
Vollmer G; Helle J; Amri H; Liu X; Arnold JT
J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):153-62. PubMed ID: 22207083
[TBL] [Abstract][Full Text] [Related]
24. 3beta-hydroxysteroid dehydrogenase is a possible pharmacological target in the treatment of castration-resistant prostate cancer.
Evaul K; Li R; Papari-Zareei M; Auchus RJ; Sharifi N
Endocrinology; 2010 Aug; 151(8):3514-20. PubMed ID: 20534728
[TBL] [Abstract][Full Text] [Related]
25. Abiraterone inhibits 3β-hydroxysteroid dehydrogenase: a rationale for increasing drug exposure in castration-resistant prostate cancer.
Li R; Evaul K; Sharma KK; Chang KH; Yoshimoto J; Liu J; Auchus RJ; Sharifi N
Clin Cancer Res; 2012 Jul; 18(13):3571-9. PubMed ID: 22753664
[TBL] [Abstract][Full Text] [Related]
26. Androgen inactivation in human lung fibroblasts: variations in levels of 17 beta-hydroxysteroid dehydrogenase type 2 and 5 alpha-reductase activity compatible with androgen inactivation.
Provost PR; Blomquist CH; Drolet R; Flamand N; Tremblay Y
J Clin Endocrinol Metab; 2002 Aug; 87(8):3883-92. PubMed ID: 12161528
[TBL] [Abstract][Full Text] [Related]
27. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
Labrie F; Bélanger A; Cusan L; Candas B
J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
[TBL] [Abstract][Full Text] [Related]
28. Mice lacking Mrp1 have reduced testicular steroid hormone levels and alterations in steroid biosynthetic enzymes.
Sivils JC; Gonzalez I; Bain LJ
Gen Comp Endocrinol; 2010 May; 167(1):51-9. PubMed ID: 20178799
[TBL] [Abstract][Full Text] [Related]
29. Multiple steroid metabolic pathways in ZR-75-1 human breast cancer cells.
Thériault C; Labrie F
J Steroid Biochem Mol Biol; 1991 Feb; 38(2):155-64. PubMed ID: 2004038
[TBL] [Abstract][Full Text] [Related]
30. Sex steroid metabolism in human peripheral blood mononuclear cells changes with aging.
Hammer F; Drescher DG; Schneider SB; Quinkler M; Stewart PM; Allolio B; Arlt W
J Clin Endocrinol Metab; 2005 Nov; 90(11):6283-9. PubMed ID: 16091484
[TBL] [Abstract][Full Text] [Related]
31. Sex steroid hormone metabolism and prostate cancer.
Soronen P; Laiti M; Törn S; Härkönen P; Patrikainen L; Li Y; Pulkka A; Kurkela R; Herrala A; Kaija H; Isomaa V; Vihko P
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):281-6. PubMed ID: 15663991
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma.
Fung KM; Samara EN; Wong C; Metwalli A; Krlin R; Bane B; Liu CZ; Yang JT; Pitha JV; Culkin DJ; Kropp BP; Penning TM; Lin HK
Endocr Relat Cancer; 2006 Mar; 13(1):169-80. PubMed ID: 16601286
[TBL] [Abstract][Full Text] [Related]
33. Profiling adrenal 11β-hydroxyandrostenedione metabolites in prostate cancer cells, tissue and plasma: UPC
du Toit T; Bloem LM; Quanson JL; Ehlers R; Serafin AM; Swart AC
J Steroid Biochem Mol Biol; 2017 Feb; 166():54-67. PubMed ID: 27345701
[TBL] [Abstract][Full Text] [Related]
34. Interaction of delta-5-androstene-3beta, 17beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue.
Poortman J; Prenen JA; Schwarz F; Thijssen JH
J Clin Endocrinol Metab; 1975 Mar; 40(3):373-9. PubMed ID: 163841
[TBL] [Abstract][Full Text] [Related]
35. DHEA metabolism in prostate: For better or worse?
Arnold JT
Mol Cell Endocrinol; 2009 Mar; 301(1-2):83-8. PubMed ID: 19013497
[TBL] [Abstract][Full Text] [Related]
36. Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3).
Penning TM; Burczynski ME; Jez JM; Lin HK; Ma H; Moore M; Ratnam K; Palackal N
Mol Cell Endocrinol; 2001 Jan; 171(1-2):137-49. PubMed ID: 11165022
[TBL] [Abstract][Full Text] [Related]
37. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells.
Le H; Arnold JT; McFann KK; Blackman MR
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782
[TBL] [Abstract][Full Text] [Related]
38. Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes--androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens.
Schmidt M; Weidler C; Naumann H; Anders S; Schölmerich J; Straub RH
Arthritis Res Ther; 2005; 7(5):R938-48. PubMed ID: 16207335
[TBL] [Abstract][Full Text] [Related]
39. Specific estradiol biosynthetic pathway in choriocarcinoma (JEG-3) cell line.
Samson M; Labrie F; Luu-The V
J Steroid Biochem Mol Biol; 2009 Sep; 116(3-5):154-9. PubMed ID: 19465125
[TBL] [Abstract][Full Text] [Related]
40. Expression of steroidogenic enzymes and synthesis of sex steroid hormones from DHEA in skeletal muscle of rats.
Aizawa K; Iemitsu M; Maeda S; Jesmin S; Otsuki T; Mowa CN; Miyauchi T; Mesaki N
Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E577-84. PubMed ID: 17018772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
